e-bid for the rate contract cum empanelment of analytical testing laboratories for the test and analysis of drugs - 1 driedhuman anti haemophlic fractionip ( dried factor viii fraction ip ) 250iu / vial ( iv use ) 2 humanalbumin solution ip 20% 3 rh-erythropoetininj ip 10000 iu 4 rh-erythropoetininj ip 2000iu 5 rh-erythropoetininjip 4000 iu 6 streptokinase injection 15 lac units ip 7 anti a blood grouping serum ip ( anti a monoclonal serum ) 8 anti b blood grouping serum ip ( anti b mono clonal serum ) 9 anti d ( rh ) blood grouping serum ip / anti d blood grouping serum ip 10 vdrl antigen ( with + ve and - ve control ) / rpr slide kit 11 biphasic isophane insulin inj ip ( 30 % soluble insulin and 70 % isophane insulin ) inj. 40 iu / ml ( r-dna origin ) 12 isophane insulin injip 40 iu / ml 13 insulin injection ip ( soluble insulin / neutral insulin injection ) 40 iu / ml ( r.dna origin ) 14 human anti d immunoglobulin injection ip 300mcg ( im use ) 15 human anti d immunoglobulin ip 150 mcg / human anti d immunoglobulin150 mcg 16 human rabies immunoglobulin inj ip 150 iu / ml 17 rabies vaccine human ( cell culture ) ip ( intradermal ) 2.5 iu 18 rabies vaccine human ( cell culture ) ip ( intramuscular ) 2.5 iu / dose 19 snake venum anti serum ip ( lyophilized ) polyvalent anti snake venum, serum enzyme refined.contain purified equine globulins.1 ml of serum neutralizes 0.6 mg of cobra venum, 0.45 mg of common kraite ( bungaras ) venum ( details in rc ) 20 tetanus immunoglobulin ip 250 iu / vial 21 tetanus vaccine ( adsorbed ) ip 5 ml vial 22 factor ix concentrate ( purified ) ip 500-600 i.u. ( human coagulation factor ix ) 23 anti inhibitor coagulation complex ( human plasma protein with a factor viii inhibitor bypassing activity of 500 i.u. per vial ) 24 rabies antiserum ip ( equine ) 300 units per ml contains equine anti-rabies immunoglobulin fragments ( i.m. / sc use ) 25 diphtheria antitoxin ip 10000 iu 26 alpha interferon injection interferon alpha 2 concentrated solution ip 3 million unit 27 filgrastim injection ip ( granulocyte colony stimulating factor ) ( sc / iv use ) 300 mcg 28 urokinase injection 5 lac unit ( lyophilized ) 29 normal human intravenous immunoglobulin ip5g / 100ml 30 surfactant for intratrecheal instillation ( natural bovine lung surfactant ) 31 insulin glargine 3ml ip ( 100iu / ml ) with 15 insulin syringes and needles / cartridge 3ml ( 100iu / ml ) with 15 needles and 1 pen per 20 cartridges 32 dried factor viii fraction ip ( iv use ) 500 iu / vial 33 dried factor viii fraction ip ( iv use ) 1000 iu / vial 34 recombinant coagulation factor viia 1mg 35 recombinant coagulation factor viia 2mg 36 insulin glargine ip 10 ml vial ( 100 iu / ml ) with 30 insuline syringes with needle 37 bevacizumab injection 400 mg 38 bevacizumab injection 100 mg 39 recombinant f ix500 iu with diluent 40 3rd generation recombinant f viii250 iu with diluent 41 3rd generation recombinant f viii 1000 iu with diluent 42 hepatitis b immunologlobin injection ip 200 i.u 43 human chorionic gonadotropin injection ip 5000 i.u. 44 inj poractant alpha 80 mg / ml in pack of 1.5 ml ( detail in rc ) 45 human immunoglobulin inj with 12%igm, 12%iga, 76%igg in pack of 10ml ( 0.5gm ) 46 adalimumab 40 mg inj. 47 prostaglandin 500mcg / ml inj. 1 ml vial 48 avelumab 200 mg inj. 49 botulinum toxin type a for injection 100 iu 50 botulinum toxin type a for injection 50 iu 51 cetuximab 100 mg inj. 52 cetuximab 500mg inj. 53 daratumumab 100 mg inj. 54 daratumumab400 mg inj. 55 darbepoietin alfa 100mcg inj. 56 darbepoietin alfa 200 mcg inj. 57 darbepoietin alfa 500mcg inj. 58 degludec insulin 100iu / ml injection 3ml 59 denosumab 120 mg inj. 60 detemir insuline 100iu / ml injection 3ml 61 durvalumab 120 mg inj. 62 durvalumab 500mg inj. 63 fsh 75 iu inj. 64 horseatg ( anti thymocyte globulin ) 250 mg inj. 65 hp hmg ( highly human menopausal parodied gonadotropin ) 150 iu inj. ip 66 inotuzumab ozogamicin injection 1mg 67 insulin aspart ip 100iu / ml injection 3 ml 68 insulin glulisine ( monocomponent insulin glulisine ) 100 iu / ml injection 3 ml 69 insulin lispro ip injection 70 interferon beta 1 a injection ip 30mcg 71 natalizumab 300 mg inj. 72 nimotuzumab 50 mg inj. 73 omalizumab 150 mg vial inj. 74 peg asparaginase 3750 iu 5 ml inj. 75 peg filgrastim injection 6mg inj. 76 pertuzumab injection 600 mg and transtuzumab 600 mg in 10 ml 77 ranibizumab injection ( 10mg / ml ) 2.3mg / 0.23ml per vial 78 rasburicase 1.5 mg inj. 79 recombinant fsh 150 iu inj. 80 recombinant fsh 300iu inj. 81 recombinant lh 75iu inj. 82 reteplase 18 mg inj. 83 rituximab 100 mg inj. ip 84 rituximab 500 mg inj. ip 85 romiplostim 250 mcg inj. 86 romiplostim 500 mcg inj. 87 secukinumab 150 mg inj. 88 tenecteplase 20mg inj. 89 tenecteplase 40 mg inj. 90 t pa 20mg alteplase for injection 91 t pa 50mg alteplase for injection 92 trastuzumab 440 mg inj. 93 trastuzumab150mg inj. 94 insulin glargine 300 iu ip per ml inj. ip 1 prefilled pen of 1.5ml 95 rabbit atg ( anti thymocyte globulin ) 25mg / 5ml inj. 96 human albumin 20% in 50 ml vial inj. ip 97 tetanus vaccine ( adsorbed ) ip in 0.5 ml inj. 98 glycopegylated extended half life nonacog beta pegol f ix 500iu 99 glycopegylated extended half life nonacog beta pegol f ix 1000iu 100 glycopegylated extended half life factor viii 500iu 101 glycopegylated extended half life factor viii 1000iu 102 crizanlizumab 10mg / ml inj 10ml